EYPT · EyePoint, Inc.
AI read · Bad for EYPT
The AI's read
The claims concern statements about EyePoint’s lead drug candidate, creating legal and reputation risk. EyePoint says the claims lack merit and plans to fight, but no court outcome is reported.